Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon CNP as Treatment for Achondroplasia

NEXT STORY
Oasmia Pharmaceutical AB (publ)
PREV STORY
IMV Inc. Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Markets for Veterinary Laboratory Testing Services, 2015-2030 – ABAXIS, IDEXX Labs, Heska Corp, Pfizer Animal Health, and Neogen Corp are the Major Players

author_avatar
NASDAQ Market News

Vor to Develop Multi-Targeted CAR-Ts with Abound Bio

author_avatar
NASDAQ Market News

Sarepta Therapeutics’ Gene Therapy SRP-9001 Shows Statistically Significant Functional Improvements Compared to Pre-specified Matched External Control in Part 2 of Study SRP-9001-102 for the Treatment of Duchenne Muscular Dystrophy

author_avatar
NASDAQ Market News